Related Experiment Video
Updated: May 2, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Nontuberculous mycobacterial pulmonary infections
Margaret M Johnson1, John A Odell1
11 Division of Pulmonary Medicine, 2 Department of Cardiothoracic Surgery, Mayo Clinic, Florida, USA.
Nontuberculous mycobacteria (NTM) cause increasing pulmonary infections worldwide, often requiring prolonged treatment. Surgery may be necessary for localized or drug-resistant NTM lung disease, especially with complications like hemoptysis.
Area of Science:
- Pulmonology
- Infectious Diseases
- Microbiology
Background:
- Nontuberculous mycobacteria (NTM) infections of the lungs are a growing global health concern.
- Commonly implicated NTM species include Mycobacterium avium complex (MAC), Mycobacterium kansasii, and Mycobacterium abscessus.
- Diagnosis requires integrating microbiological findings with clinical and radiographic evidence of active infection.
Purpose of the Study:
- To review the practical aspects of diagnosing and managing thoracic NTM infections.
- To emphasize indications for surgical intervention in NTM lung disease.
- To summarize outcomes of surgical treatment for NTM infections.
Main Methods:
- Literature review focusing on diagnosis, medical management, and surgical treatment of NTM pulmonary infections.
- Emphasis on clinical presentation, radiographic findings, and microbiological identification.
- Analysis of indications for and results of surgical resection.
Main Results:
- NTM infections are challenging to eradicate, necessitating prolonged combination therapy.
- Recurrent infections or relapse are common.
- Surgery is indicated for localized disease, drug-resistant infections, hemoptysis, or abscess formation.
Conclusions:
- Effective management of NTM lung disease requires a multidisciplinary approach.
- Surgical intervention plays a crucial role in selected cases of NTM thoracic infections.
- Outcomes of surgery are generally favorable in appropriate patient selections.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Atypical Pneumonia

